<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The antithrombotic efficacy of the prostacyclin analogue naxaprostene has been tested in rabbits with copper coil-induced carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>With oral pretreatment, 10 mg/kg naxaprostene prevented thrombotic <z:mp ids='MP_0006134'>arterial occlusion</z:mp>; with intraduodenal pretreatment the efficacy of naxaprostene was enhanced and 1 mg/kg was sufficient to exert an antithrombotic effect </plain></SENT>
<SENT sid="2" pm="."><plain>The final average carotid blood flow at 180 min compared to the flow immediately before <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> induction was 85 +/- 25% and 47 +/- 18% in animals treated with 10 mg/kg p.o. resp </plain></SENT>
<SENT sid="3" pm="."><plain>1 mg/kg i.d. naxaprostene </plain></SENT>
<SENT sid="4" pm="."><plain>Parallel to the antithrombotic effect, naxaprostene inhibited <z:chebi fb="13" ids="16761">ADP</z:chebi>- and collagen-induced fall in circulating platelets </plain></SENT>
<SENT sid="5" pm="."><plain>In anesthetized rabbits there was no dissociation between antithrombotic and hypotensive effects of naxaprostene </plain></SENT>
</text></document>